We are live on ! Find out more
VINC

Vincerx Pharma, Inc. Common Stock

Delisted

VINC was delisted on the 22nd of April, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
RCMNY
1
Rubric Capital Management (New York)
New York
$2.91M
SRC
2
Sage Rhino Capital
California
$2.29M
AAA
3
Affinity Asset Advisors
New York
$2.06M +$171K +5,934 +9%
RSCM
4
Rock Springs Capital Management
Maryland
$1.53M +$423K +14,719 +36%
TCM
5
Tang Capital Management
California
$1.42M
Holocene Advisors
6
Holocene Advisors
New York
$1.05M
Citadel Advisors
7
Citadel Advisors
Florida
$863K +$2.36K +82 +0.3%
Vanguard Group
8
Vanguard Group
Pennsylvania
$720K -$82.4K -2,863 -10%
SM
9
Sabby Management
Florida
$698K +$7.19K +250 +1%
SSA
10
Schonfeld Strategic Advisors
New York
$663K +$269K +9,362 +64%
CC
11
Clearline Capital
New York
$624K
KCM
12
Kingdon Capital Management
New York
$531K
Point72 Asset Management
13
Point72 Asset Management
Connecticut
$476K
Renaissance Technologies
14
Renaissance Technologies
New York
$426K -$5.5K -191 -1%
BBA
15
Baker Bros. Advisors
New York
$333K
Millennium Management
16
Millennium Management
New York
$287K -$142K -4,949 -32%
Russell Investments Group
17
Russell Investments Group
United Kingdom
$284K +$297K +10,311 New
ECM
18
ExodusPoint Capital Management
New York
$238K +$104K +3,610 +72%
BlackRock
19
BlackRock
New York
$191K -$5.18K -180 -3%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$189K
SCM
21
Sio Capital Management
New York
$141K
E
22
Ergoteles
New York
$98K -$13.9K -484 -12%
LP
23
LMR Partners
United Kingdom
$87K
Two Sigma Investments
24
Two Sigma Investments
New York
$75K -$7.77K -270 -9%
State Street
25
State Street
Massachusetts
$60K